ストックスクリーナーアプリを入手
0.4896
3.49%
-0.0177
プレマーケット:
.53
0.0404
+8.25%
前日終値:
$0.5073
開ける：
$0.51
24時間の取引高:
916.90K
Relative Volume:
1.01
時価総額：
$42.18M
収益：
$2.24M
当期純損益:
$-136.67M
株価収益率:
-0.2138
EPS:
-2.29
ネットキャッシュフロー:
$-102.08M
1週間 パフォーマンス:
-13.33%
1か月 パフォーマンス:
-18.44%
6か月 パフォーマンス:
-33.00%
1年 パフォーマンス:
-71.53%
1日の値動き範囲:
$0.4822
$0.5499
1週間の範囲:
$0.4822
$0.5728
52週間の値動き範囲:
$0.3418
$2.05
Century Therapeutics Inc Stock (IPSC) Company Profile
名前
Century Therapeutics Inc
セクター
電話
215-981-4000
住所
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
IPSC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.4896 | 43.71M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-08 | 開始されました | Rodman & Renshaw | Buy |
| 2023-08-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-27 | 開始されました | Chardan Capital Markets | Buy |
| 2022-10-31 | 開始されました | Guggenheim | Buy |
| 2022-10-10 | 開始されました | Canaccord Genuity | Buy |
| 2022-05-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-12 | 開始されました | William Blair | Mkt Perform |
| 2021-07-13 | 開始されました | BofA Securities | Buy |
| 2021-07-13 | 開始されました | JP Morgan | Overweight |
| 2021-07-13 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Century Therapeutics Inc (IPSC) 最新ニュース
Backtesting results for Century Therapeutics Inc. trading strategiesLong-Term Safety Investment Analysis Report - Newser
What institutions are buying Century Therapeutics Inc. stock nowFree Risk-Adjusted Picks With Exit Strategy - Newser
Philly’s biotech industry keeps losing local jobs in a volatile market - WHYY
Earnings visualization tools for Century Therapeutics Inc.ROI Focused Setup With Drawdown Analysis - Newser
Measuring Century Therapeutics Inc.’s beta against major indicesBuy Signal Forecast With Short-Term Data - Newser
Technical analysis overview for Century Therapeutics Inc. stockDay Trading Plan with Entry Risk Management - Newser
Is Century Therapeutics Inc. showing signs of accumulationTrade Setup Builder with Custom Alerts - Newser
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
How Century Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Century Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Breakout Traders Target Century Therapeutics Inc. on Recovery SetupVerified Signal From Chart Patterns Detected - beatles.ru
How does Century Therapeutics Inc. compare to its industry peersMaximize portfolio growth with expert advice - Jammu Links News
Century Therapeutics Inc. Stock Analysis and ForecastGet expert advice on portfolio optimization - Jammu Links News
Is Century Therapeutics Inc. a good long term investmentSkyrocketing returns - Jammu Links News
What catalysts could drive Century Therapeutics Inc. stock higher in 2025Build wealth faster with high-performing stocks - Jammu Links News
What are the technical indicators suggesting about Century Therapeutics Inc.Achieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for Century Therapeutics Inc.Capitalize on market trends before they peak - Jammu Links News
What are Century Therapeutics Inc. company’s key revenue driversRecord-breaking capital gains - Jammu Links News
How volatile is Century Therapeutics Inc. stock compared to the marketFree High-Return Strategy Alerts - Jammu Links News
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN
Is Century Therapeutics Inc. stock overvalued or undervaluedDiscover hidden gems in the stock market - Jammu Links News
Comparing Praxsyn (OTCMKTS:PXYN) & Century Therapeutics (NASDAQ:IPSC) - Defense World
What makes Century Therapeutics Inc. stock price move sharplyRisk Managed Watchlist with Breakout Picks - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockHigh Reward Investment Strategy for Beginners - Newser
Century Therapeutics (NASDAQ:IPSC) versus Biomerica (NASDAQ:BMRA) Financial Comparison - Defense World
What is Century Therapeutics Inc. company’s growth strategyMarket Forecast Recommendation With Low Risk - Jammu Links News
Will Century Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsAsset Safety Selection Using Quantitative Analysis - Newser
Published on: 2025-07-30 19:14:22 - metal.it
Century Therapeutics (NASDAQ:IPSC) Shares Down 8.7% – Here’s Why - Defense World
Published on: 2025-07-29 18:11:16 - metal.it
Backtesting results for Century Therapeutics Inc. trading strategies Short Term Gain Strategy with AI Logic - Newser
Century Therapeutics Inc (IPSC) 財務データ
収益
当期純利益
現金流量
EPS
1.02%
3.70%
大文字化:
|
ボリューム (24 時間):